NEPH vs XRAY · P/E 48, rev $14.2M vs rev $3.68B
Nephros Inc (NEPH) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Nephros Inc (NEPH) is a medical instruments & supplies company listed on US.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported NEPH revenue for 2024-12-31 was $14.2M. Net income was $74.0K. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
Latest reported XRAY revenue for 2025-12-31 was $3.68B. Net income was -$598.0M. Revenue was down 3.0% from 2024-12-31 to 2025-12-31. XRAY currently screens at market cap $2.01B.
NEPH currently screens at market cap $40.9M and trailing P/E 48.3. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the NEPH and XRAY stock pages for the full models.
Not investment advice.